Concord Drugs consolidated net profit declines 93.88% in the June 2024 quarter
Net profit of Concord Drugs declined 93.88% to Rs 0.03 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended June 2023. Sales rose 30.18% to Rs 11.69 crore in the quarter ended June 2024 as against Rs 8.98 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended | ||
| Jun. 2024 | Jun. 2023 | % Var. | |
| Sales | 11.69 | 8.98 | 30 |
| OPM % | 7.10 | 16.26 | - |
| PBDT | 0.38 | 1.02 | -63 |
| PBT | 0.04 | 0.64 | -94 |
| NP | 0.03 | 0.49 | -94 |
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
₹0 Brokerage *
Open Demat Account
